Xenon Pharmaceuticals (NASDAQ:XENE) Reaches New 1-Year High at $43.69

Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Rating) reached a new 52-week high during trading on Tuesday . The company traded as high as $43.69 and last traded at $43.37, with a volume of 224615 shares. The stock had previously closed at $42.35. Analyst Ratings Changes A number of equities research analysts recently issued reports on […]

Related Keywords

Stifel Nicolaus ,Simonn Pimstone ,Simon Neil Pimstone ,Ian Mortimer ,Xenon Pharmaceuticals ,Cantor Fitzgerald ,Securities Exchange Commission ,Advisors Asset Management Inc ,Xenon Pharmaceuticals Price Performance ,Xenon Pharmaceuticals Inc ,Jpmorgan Chase Co ,Cubist Systematic Strategies ,Nasdaq ,Needham Company ,News Ratings For Xenon Pharmaceuticals Daily ,Institutional Investors Weigh In On Xenon Pharmaceuticals ,Wells Fargo Company ,Get Rating ,Director Simon ,Exchange Commission ,Asset Management ,Systematic Strategies ,Xenon Pharmaceuticals Daily ,